Coeptis Therapeutics S-4 Declared Effective by SEC, Proxy Mailing Begins in Anticipation of the Merger Transaction with Z Squared - Coeptis Therapeutics ( NASDAQ:COEP )

Written by:Content Normalization Editor transformation

Share this article

📰 This is a news preview

This article contains a brief summary. Click the button below to read the full story at the original source.

WEXFORD, Pa., Jan. 06, 2026 ( GLOBE NEWSWIRE ) -- Coeptis Therapeutics Holdings, Inc. ( Nasdaq: COEP ) ( "Coeptis" or the "Company" ) , a next-gen technology and biopharmaceutical company, , announced today that its registration statement on Form S-4 ( File No. 333-288329 ) ( as amended, the ...

Written by: Globe Newswire

Original Source:

https://www.benzinga.com/pressreleases/26/01/g49720425/coeptis-therapeutics-s-4-declared-effective-by-sec-proxy-mailing-begins-in-anticipation-of-the-mer

This article is republished with proper attribution to the original publisher. We appreciate their journalism and encourage readers to support the original source.